ProJenX
New Suffolk
About ProJenX
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $21.1M
- Funding stage: Early Stage Venture
- Last round: Grant (Jun 2024)
- Website: projenx.com
- Phone: 917-268-1458
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/projenx-54720 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.